{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:40:21Z","timestamp":1793209221730,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014418","name":"Harbin Medical University Cancer Hospital","doi-asserted-by":"publisher","award":["JJJQ 2024-02"],"award-info":[{"award-number":["JJJQ 2024-02"]}],"id":[{"id":"10.13039\/100014418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373372"],"award-info":[{"award-number":["82373372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.canlet.2025.217946","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T06:43:41Z","timestamp":1753166621000},"page":"217946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response"],"prefix":"10.1016","volume":"631","author":[{"given":"Shuling","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8104-6750","authenticated-orcid":false,"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2025.217946_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a cancer journal for clinicians"},{"issue":"17","key":"10.1016\/j.canlet.2025.217946_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174245","article-title":"Immunotherapy for colorectal cancer with high microsatellite instability: the ongoing search for biomarkers","volume":"15","author":"Ros","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.canlet.2025.217946_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010154","article-title":"Genetic alterations of NF-\u03baB and its regulators: a rich platform to advance colorectal cancer diagnosis and treatment","volume":"25","author":"Alipourgivi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.canlet.2025.217946_bib4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/1078-0432.CCR-22-0784","article-title":"The crossroads of cancer epigenetics and immune checkpoint therapy","volume":"29","author":"Micevic","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.canlet.2025.217946_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.it.2020.06.002","article-title":"The contribution of epigenetics to cancer immunotherapy","volume":"41","author":"Villanueva","year":"2020","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217946_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13148-024-01740-9","article-title":"Epigenetics and immunotherapy in colorectal cancer: progress and promise","volume":"16","author":"Dang","year":"2024","journal-title":"Clin. Epigenet."},{"issue":"4","key":"10.1016\/j.canlet.2025.217946_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41591-024-02813-1","article-title":"Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS\/pMMR colorectal cancer: a randomized phase 2 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.canlet.2025.217946_bib8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/acs.jmedchem.4c02613","article-title":"Targeting KAT6A\/B as a new therapeutic strategy for cancer therapy","volume":"68","author":"Zheng","year":"2025","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.canlet.2025.217946_bib9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/2159-8290.CD-20-1459","article-title":"KAT6A and ENL form an epigenetic transcriptional control module to drive critical leukemogenic gene-expression programs","volume":"12","author":"Yan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217946_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129948","article-title":"Identification of triazolyl KAT6 inhibitors via a templated fragment approach","volume":"113","author":"Chen","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.canlet.2025.217946_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ydbio.2015.04.011","article-title":"Mesodermal expression of moz is necessary for cardiac septum development","volume":"403","author":"Vanyai","year":"2015","journal-title":"Dev. Biol."},{"issue":"12","key":"10.1016\/j.canlet.2025.217946_bib12","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/j.celrep.2016.08.056","article-title":"Acetylation of the Cd8 locus by KAT6A determines memory T cell diversity","volume":"16","author":"Newman","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.canlet.2025.217946_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-024-01610-0","article-title":"The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency","volume":"17","author":"Sheridan","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2025.217946_bib14","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/s41591-024-03060-0","article-title":"Inhibition of lysine acetyltransferase KAT6 in ER(+)HER2(-) metastatic breast cancer: a phase 1 trial","volume":"30","author":"Mukohara","year":"2024","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.canlet.2025.217946_bib15","article-title":"The recruitment and immune suppression mechanisms of myeloid-derived suppressor cells and their impact on bone metastatic cancer","volume":"8","author":"Li","year":"2025","journal-title":"Cancer reports (Hoboken, N.J.)"},{"key":"10.1016\/j.canlet.2025.217946_bib16","series-title":"Biorxiv : the Preprint Server for Biology","article-title":"Catalytic inhibition of KAT6\/KAT7 enhances the efficacy and overcomes primary and acquired resistance to menin inhibitors in MLL leukaemia","author":"Gordon","year":"2024"},{"issue":"1","key":"10.1016\/j.canlet.2025.217946_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001895","article-title":"Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer","volume":"9","author":"Liu","year":"2021","journal-title":"Journal for immunotherapy of cancer"},{"issue":"2","key":"10.1016\/j.canlet.2025.217946_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2025.217946_bib19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev-immunol-101721-032910","article-title":"Regulation of the cGAS-STING pathway","volume":"43","author":"Zhang","year":"2025","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217946_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002528","article-title":"MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer","volume":"9","author":"Wu","year":"2021","journal-title":"Journal for immunotherapy of cancer"},{"issue":"2","key":"10.1016\/j.canlet.2025.217946_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020462","article-title":"Decitabine augments chemotherapy-induced PD-L1 upregulation for PD-L1 blockade in colorectal cancer","volume":"12","author":"Huang","year":"2020","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.canlet.2025.217946_bib22","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.7150\/jca.44622","article-title":"HDAC inhibitor, CG-745, enhances the anti-cancer effect of Anti-PD-1 immune checkpoint inhibitor by modulation of the immune microenvironment","volume":"11","author":"Kim","year":"2020","journal-title":"J. Cancer"},{"issue":"15","key":"10.1016\/j.canlet.2025.217946_bib23","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.7150\/ijbs.73264","article-title":"TMP195 exerts Antitumor effects on colorectal cancer by promoting M1 macrophages polarization","volume":"18","author":"Han","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2025.217946_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1308264","article-title":"Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors","volume":"14","author":"Liang","year":"2023","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.canlet.2025.217946_bib25","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1158\/0008-5472.CAN-17-1388","article-title":"Histone acetyltransferase KAT6A upregulates PI3K\/AKT signaling through TRIM24 binding","volume":"77","author":"Lv","year":"2017","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.canlet.2025.217946_bib26","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401151R","article-title":"Circ_0005397 inhibits ferroptosis of pancreatic cancer cells by up-regulating PCBP2 through KAT6A\/H3K9Ac","volume":"38","author":"Qu","year":"2024","journal-title":"FASEB J. : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"34","key":"10.1016\/j.canlet.2025.217946_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202400140","article-title":"KAT6A condensates impair PARP1 trapping of PARP inhibitors in ovarian cancer","volume":"11","author":"Zhan","year":"2024","journal-title":"Adv. Sci."},{"issue":"13","key":"10.1016\/j.canlet.2025.217946_bib28","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.7150\/thno.57455","article-title":"KAT6A, a novel regulator of \u03b2-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217946_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbrc.2021.09.009","article-title":"KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP","volume":"585","author":"Jin","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2025.217946_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41416-022-01784-9","article-title":"Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression","volume":"127","author":"Zhao","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"20","key":"10.1016\/j.canlet.2025.217946_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202100014","article-title":"KAT6A acetylation of SMAD3 regulates myeloid-derived suppressor cell recruitment, metastasis, and immunotherapy in triple-negative breast cancer","volume":"8","author":"Yu","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.canlet.2025.217946_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.freeradbiomed.2024.11.028","article-title":"Cold atmospheric plasma restores skewed macrophage polarization in triple negative breast cancers via enhancing KAT6A acetylation","volume":"226","author":"Zhu","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.canlet.2025.217946_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1403533","article-title":"Immune checkpoint inhibitors in colorectal cancer: limitation and challenges","volume":"15","author":"Yan","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217946_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-025-01676-0","article-title":"Effectiveness and safety of immune checkpoint inhibitors in colorectal cancer: a systematic review of real-world studies","author":"Kong","year":"2025","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217946_bib35","article-title":"Evaluation of the efficacy and safety of first- and second-line immunotherapy in patients with metastatic colorectal cancer: a systematic review and network meta-analysis based on randomized controlled trials","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525005154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525005154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:57:17Z","timestamp":1772762237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525005154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"alternative-id":["S0304383525005154"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217946","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217946"}}